Agenus Inc (NASDAQ:AGEN)

1.96
Delayed Data
As of Sep 26
 -0.17 / -7.98%
Today’s Change
1.25
Today|||52-Week Range
5.94
-39.13%
Year-to-Date
AstraZeneca's (AZN) Ultomiris Gets EC Nod for New Indication
Sep 26 / Zacks.com - Paid Partner Content
Is Trending Stock Agenus Inc. (AGEN) a Buy Now?
Sep 19 / Zacks.com - Paid Partner Content
Merck's (MRK) Stock Up on Januvia Patent Win Against Viatris
Sep 23 / Zacks.com - Paid Partner Content
J&J (JNJ) Announces $5B Stock Repurchase Program, Stock Up
Sep 15 / Zacks.com - Paid Partner Content
Agenus (AGEN) Stock Sinks As Market Gains: What You Should Know
Sep 19 / Zacks.com - Paid Partner Content
Key Factors Driving Merck's (MRK) Outperformance This Year
Sep 14 / Zacks.com - Paid Partner Content
Philips (PHG) to Showcase New Innovations & Cardiac Solutions
Sep 19 / Zacks.com - Paid Partner Content
Pfizer (PFE), BioNTech Omicron BA.4, BA.5 Boosters Get CHMP Nod
Sep 13 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Gets CHMP Nod for Evusheld to Treat COVID
Sep 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close2.13
Today’s open2.13
Day’s range1.95 - 2.19
Volume202,478
Average volume (3 months)4,705,802
Market cap$604.6M
Data as of 4:01pm ET, 09/26/2022

Growth & Valuation

Earnings growth (last year)+89.96%
Earnings growth (this year)-536.36%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+235.34%
P/E ratio10.3
Price/Sales2.49
Price/Book15.93

Competitors

 Today’s
change
Today’s
% change
NSTGNanoString Technolog...-0.18-1.38%
ALTAltimmune Inc-0.66-5.34%
MRSNMersana Therapeutics...+0.01+0.16%
MORMorphoSys AG-0.09-2.02%
Data as of 4:01pm ET, 09/26/2022

Financials

Next reporting dateNovember 8, 2022
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$295.7M
Annual profit (last year)-$23.9M
Net profit margin-8.09%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Lexington, Massachusetts

Forecasts